Advancements in Canadian biomaterials research in neurotraumatic diagnosis and therapies
Processes , Volume 7 - Issue 6
Development of biomaterials for the diagnosis and treatment of neurotraumatic ailments has been significantly advanced with our deepened knowledge of the pathophysiology of neurotrauma. Canadian research in the fields of biomaterial-based contrast agents, non-invasive axonal tracing, non-invasive scaffold imaging, scaffold patterning, 3D printed scaffolds, and drug delivery are conquering barriers to patient diagnosis and treatment for traumatic injuries to the nervous system. This review highlights some of the highly interdisciplinary Canadian research in biomaterials with a focus on neurotrauma applications.
|, , , , ,|
|Organisation||Ottawa-Carleton Chemistry Institute|
Chen, S. (Suzan), Auriat, A.M. (Angela M.), Li, T. (Tongda), Stumpf, T.R. (Taisa R.), Wylie, R. (Ryan), Chen, X. (Xiongbiao), … Tsai, E.C. (Eve C.). (2019). Advancements in Canadian biomaterials research in neurotraumatic diagnosis and therapies. Processes (Vol. 7). doi:10.3390/pr7060336